Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Mar;82(3):e55.
doi: 10.1136/annrheumdis-2020-219500. Epub 2020 Dec 4.

Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'

Marta Novella-Navarro  1 , Chamaida Plasencia-Rodríguez  2 , Carolina Tornero  2 , Victoria Navarro-Compán  2 , José Luis Cabrera-Alarcón  3 , Diana Peiteado  2 , Laura Nuño  2 , Irene Monjo  2 , Karen Franco-Gómez  2 , Alejandro Villalba  2 , Alejandro Balsa  2
Affiliations
Free article
Comment

Correspondence on: 'EULAR definition of difficult-to-treat rheumatoid arthritis'

Marta Novella-Navarro et al. Ann Rheum Dis. 2023 Mar.
Free article
No abstract available

Keywords: arthritis; biological therapy; rheumatoid; therapeutics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: AB reports grants and personal fees from AbbVie, Pfizer, Novartis and Roche; personal fees from Amgen, Sandoz, Lilly and UCB; personal fees and non-financial support from BMS; and grants, personal fees and non-financial support from Nordic, outside the submitted work. IM reports personal fees from Roche, outside the submitted work. DP reports grants from AbbVie, Lilly, MSD and Roche, outside the submitted work. AV reports grants from AbbVie, Janssen and Bristol Myers, outside the submitted work. VN-C reports grants from AbbVie, Janssen, Lilly, Novartis, Pfizer and UCB Pharma.

Comment in

Comment on

  • EULAR definition of difficult-to-treat rheumatoid arthritis.
    Nagy G, Roodenrijs NMT, Welsing PM, Kedves M, Hamar A, van der Goes MC, Kent A, Bakkers M, Blaas E, Senolt L, Szekanecz Z, Choy E, Dougados M, Jacobs JW, Geenen R, Bijlsma HW, Zink A, Aletaha D, Schoneveld L, van Riel P, Gutermann L, Prior Y, Nikiphorou E, Ferraccioli G, Schett G, Hyrich KL, Mueller-Ladner U, Buch MH, McInnes IB, van der Heijde D, van Laar JM. Nagy G, et al. Ann Rheum Dis. 2021 Jan;80(1):31-35. doi: 10.1136/annrheumdis-2020-217344. Epub 2020 Oct 1. Ann Rheum Dis. 2021. PMID: 33004335 Free PMC article.

MeSH terms

Substances